Cookie Yu

Dr. Cookie (Jinzhu) Yu is a principal at Pappas Capital. She currently serves as a director at the board of Allievex and an observer at the board of CuraSen Therapeutics. Cookie joined Pappas Capital in 2019 and is actively involved in evaluating investment opportunities for Pappas Capital. Prior to that, Cookie worked as an analyst at M. Ventures, a subsidiary of Merck KGaA, in Darmstadt, Germany. During her time at M. Ventures, Cookie performed market analysis in a wide range of life science and therapeutic areas for venture opportunities in alignment with global corporate strategies. She also supported the CFO in fund controlling.

Before entering venture investment, Dr. Cookie Yu was a researcher at Stony Brook University, where she developed platform technologies in cardiac optogenetics and single cell analysis that lead to a number of peer reviewed publications. In 2016, Cookie was selected as a recipient of the Program for Excellence in Science Award from AAAS. She supplemented her life science technical expertise with financial understanding by passing the CFA Level I exam. When she is not scouting new technologies, Cookie enjoys foraging wild mushrooms in the forests, traveling, and Latin dancing.